Rosa Serra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rosa Serra has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Michael R. Crowley
The Department of Cell Biology, The University of Alabama at Birmingham, 1918 University Boulevard 310, MCLM, Birmingham, AL 35294, USA
2 shared publicationsChenbei Chang
Department of Cell Biology, University of Alabama, Birmingham, Alabama
1 shared publication- David D. L. Bowtell
Peter MacCallum Cancer Centre, Melbourne, Australia
1 shared publication Jesus Alvarez
Department of Cell Biology, University of Alabama at Birmingham, 35294, USA
1 shared publication
Latest Publications
- 29 December 2004
- Published by Elsevier in Developmental Biology
- Vol. 279 (1) , 58-72
TGF-β, c-Cbl, and PDGFR-α the in mammary stroma
- 29 December 2004
- Published by Elsevier in Developmental Biology
- Vol. 279 (1) , 58-72
TGF-β, c-Cbl, and PDGFR-α the in mammary stroma
- Open Access
- 9 June 2004
- Published by Wiley in Developmental Dynamics
- Vol. 230 (4) , 685-699
Unique and redundant roles of Smad3 in TGF‐β–mediated regulation of long bone development in organ culture
The most well‐characterized intracellular signaling molecules for transforming growth factor‐beta (TGF‐β) are the Smads. R‐Smads interact with and are phosphorylated directly by the TGF‐β type I receptor. Phosphorylated R‐Smads can then associate with Smad4, translocate to the nucleus and regulate transcription. Specific R‐Smads transduce distinct signals for members of the TGF‐β superfamily. Smad2 and ‐3 mediate signaling by TGF‐β/activin, whereas Smad1, ‐5, and ‐8 mediate bone morphogenetic protein signaling. TGF‐β inhibits proliferation and hypertrophic differentiation in metatarsal organ cultures by a perichondrium‐dependent mechanism. To determine the mechanism of TGF‐β signaling in the perichondrium, we tested the hypothesis that TGF‐β–restricted Smad2 and Smad3 regulate chondrocyte proliferation and differentiation in embryonic metatarsal organ cultures. Perichondrium was infected with adenoviruses containing dominant‐negative forms of Smad2 (Ad‐Smad2‐3SA) and Smad3 (Ad‐Smad3ΔC). Proliferation and differentiation were measured in response to treatment with TGF‐β1. Results were compared with control bones infected with a β‐galactosidase reporter virus (Ad‐β‐gal). Infection with Ad‐Smad2‐3SA completely blocked the effects of TGF‐β1 on metatarsal development while Ad‐Smad3ΔC only partially blocked TGF‐β1 effects. To further characterize the role of Smad3 in long bone development, TGF‐β1 responsiveness in cultures from Smad3+/+ and Smad3ex8/ex8 mice were compared. Loss of Smad3 only partially blocked the effects of TGF‐β1 on differentiation. In contrast, the effects of TGF‐β1 on chondrocyte proliferation were blocked completely. We conclude that Smad2 signaling in the perichondrium can compensate for the loss of Smad3 to regulate inhibition of hypertrophic differentiation; however, Smad3 is required for TGF‐β1–mediated effects on proliferation. Developmental Dynamics 230:685–699, 2004.
- 9 June 2004
- Published by Wiley in Developmental Dynamics
- Vol. 230 (4) , 685-699
Open AccessUnique and redundant roles of Smad3 in TGF‐β–mediated regulation of long bone development in organ culture
The most well‐characterized intracellular signaling molecules for transforming growth factor‐beta (TGF‐β) are the Smads. R‐Smads interact with and are phosphorylated directly by the TGF‐β type I receptor. Phosphorylated R‐Smads can then associate with Smad4, translocate to the nucleus and regulate transcription. Specific R‐Smads transduce distinct signals for members of the TGF‐β superfamily. Smad2 and ‐3 mediate signaling by TGF‐β/activin, whereas Smad1, ‐5, and ‐8 mediate bone morphogenetic protein signaling. TGF‐β inhibits proliferation and hypertrophic differentiation in metatarsal organ cultures by a perichondrium‐dependent mechanism. To determine the mechanism of TGF‐β signaling in the perichondrium, we tested the hypothesis that TGF‐β–restricted Smad2 and Smad3 regulate chondrocyte proliferation and differentiation in embryonic metatarsal organ cultures. Perichondrium was infected with adenoviruses containing dominant‐negative forms of Smad2 (Ad‐Smad2‐3SA) and Smad3 (Ad‐Smad3ΔC). Proliferation and differentiation were measured in response to treatment with TGF‐β1. Results were compared with control bones infected with a β‐galactosidase reporter virus (Ad‐β‐gal). Infection with Ad‐Smad2‐3SA completely blocked the effects of TGF‐β1 on metatarsal development while Ad‐Smad3ΔC only partially blocked TGF‐β1 effects. To further characterize the role of Smad3 in long bone development, TGF‐β1 responsiveness in cultures from Smad3+/+ and Smad3ex8/ex8 mice were compared. Loss of Smad3 only partially blocked the effects of TGF‐β1 on differentiation. In contrast, the effects of TGF‐β1 on chondrocyte proliferation were blocked completely. We conclude that Smad2 signaling in the perichondrium can compensate for the loss of Smad3 to regulate inhibition of hypertrophic differentiation; however, Smad3 is required for TGF‐β1–mediated effects on proliferation. Developmental Dynamics 230:685–699, 2004.
- 16 December 2003
- Published by Wiley in Birth Defects Research Part C: Embryo Today: Reviews
- Vol. 69 (4) , 333-351
TGF‐β signaling in human skeletal and patterning disorders
Members of the transforming growth factor beta (TGF‐β) family of multifunctional peptides are involved in almost every aspect of development. Model systems, ranging from genetically tractable invertebrates to genetically engineered mice, have been used to determine the mechanisms of TGF‐β signaling in normal development and in pathological situations. Furthermore, mutations in genes for the ligands, receptors, extracellular modulators, and intracellular signaling molecules have been associated with several human disorders. The most common are those associated with the development and maintenance of the skeletal system and axial patterning. This review focuses on the mechanisms of TGF‐β signaling with special emphasis on the molecules involved in human disorders of patterning and skeletal development. Birth Defects Research (Part C) 69:333–351, 2003.
- 16 December 2003
- Published by Wiley in Birth Defects Research Part C: Embryo Today: Reviews
- Vol. 69 (4) , 333-351
TGF‐β signaling in human skeletal and patterning disorders
Members of the transforming growth factor beta (TGF‐β) family of multifunctional peptides are involved in almost every aspect of development. Model systems, ranging from genetically tractable invertebrates to genetically engineered mice, have been used to determine the mechanisms of TGF‐β signaling in normal development and in pathological situations. Furthermore, mutations in genes for the ligands, receptors, extracellular modulators, and intracellular signaling molecules have been associated with several human disorders. The most common are those associated with the development and maintenance of the skeletal system and axial patterning. This review focuses on the mechanisms of TGF‐β signaling with special emphasis on the molecules involved in human disorders of patterning and skeletal development. Birth Defects Research (Part C) 69:333–351, 2003.
- 1 December 2003
- Published by SAGE Publications in Breast Disease
- Vol. 18 (1) , 61-73
TGF-β in Mammary Gland Development and Breast Cancer
TGF-β is now recognized as an important factor regulating normal mammary gland development as well as breast cancer. In development, TGF-β regulates branching morphogenesis and differentiation by acting on both epithelial and stromal cells. TGF-β als
- 1 December 2003
- Published by SAGE Publications in Breast Disease
- Vol. 18 (1) , 61-73
TGF-β in Mammary Gland Development and Breast Cancer
TGF-β is now recognized as an important factor regulating normal mammary gland development as well as breast cancer. In development, TGF-β regulates branching morphogenesis and differentiation by acting on both epithelial and stromal cells. TGF-β als